Evidence map›Paper›PMID 41323048›Full record

ArticleCase reports in oncology

Isolated Leptomeningeal Carcinomatosis in Triple-Negative Breast Cancer: A Case Report.

Marilena Karaferi, Alkistis Papatheodoridi, Eleni Zografos, Maria Kaparelou, Aristea Maria Papanota, Constantinos G Zografos, Vasiliki Michalaki, Meletios-Athanasios Dimopoulos, Flora Zagouri

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marilena KaraferiDepartment of Clinical Therapeutics, "Alexandra" General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Alkistis PapatheodoridiDepartment of Clinical Therapeutics, "Alexandra" General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Eleni ZografosDepartment of Clinical Therapeutics, "Alexandra" General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Maria KaparelouDepartment of Clinical Therapeutics, "Alexandra" General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Aristea Maria PapanotaDepartment of Clinical Therapeutics, "Alexandra" General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Constantinos G ZografosOncology Unit, 2nd Department of Surgery, Aretaieion Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Vasiliki MichalakiOncology Unit, 2nd Department of Surgery, Aretaieion Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Meletios-Athanasios DimopoulosDepartment of Clinical Therapeutics, "Alexandra" General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Flora ZagouriDepartment of Clinical Therapeutics, "Alexandra" General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Leptomeningeal carcinomatosis (LC) is a rare but devastating complication that can arise from various cancers, particularly breast cancer. Case Presentation: We present the case of a female patient with early onset triple-negative breast cancer (TNBC) who developed isolated LC shortly after completing neoadjuvant and adjuvant treatment. The patient had no evidence of parenchymal brain metastases at the time of LC diagnosis. Our patient received treatment with both intrathecal and systemic chemotherapy. While there was a brief period of clinical improvement, she subsequently developed brain metastases and ultimately succumbed to its complications. Isolated LC is an extremely rare occurrence, as leptomeningeal metastasis usually presents concurrently with parenchymal metastases. This case is particularly notable for the development of LC as the sole site of metastasis following completion of adjuvant therapy. Conclusion: This case highlights the importance of recognizing LC in patients with TNBC, even in the absence of other metastatic sites. Our report, along with a concise review of current literature, aims to improve recognition and treatment options for this rare and clinically heterogeneous entity.

Indexed as

Intrathecal chemotherapyLeptomeningeal carcinomatosisNeoadjuvant treatmentSystemic treatmentTriple-negative breast cancer

Identifiers

PMID41323048
PMCPMC12659012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.